Workflow
公司业绩指标分析
icon
Search documents
Carnival (CCL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-09-29 16:01
Group 1 - Carnival reported $8.15 billion in revenue for the quarter ended August 2025, a year-over-year increase of 3.3% [1] - EPS for the same period was $1.43, compared to $1.27 a year ago, representing an EPS surprise of +8.33% over the consensus estimate of $1.32 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $8.07 billion by +0.99% [1] Group 2 - Key metrics monitored include ALBDs at 24.6 million, occupancy percentage at 112%, and passenger cruise days (PCDs) at 27.5 million [4] - Fuel cost per metric ton consumed was reported at $607.00, higher than the estimated $595.27 [4] - Net yields per ALBD were $249.11, surpassing the average estimate of $247.58 [4] Group 3 - Revenues from onboard and other sources were $2.72 billion, exceeding the average estimate of $2.66 billion, with a year-over-year change of +2.5% [4] - Revenues from passenger tickets reached $5.43 billion, compared to the average estimate of $5.34 billion, reflecting a year-over-year change of +3.7% [4] - Carnival's stock has returned -4% over the past month, while the Zacks S&P 500 composite increased by +2.9% [3]
Compared to Estimates, AutoZone (AZO) Q4 Earnings: A Look at Key Metrics
ZACKS· 2025-09-23 14:31
Financial Performance - For the quarter ended August 2025, AutoZone reported revenue of $6.24 billion, reflecting a 0.6% increase year-over-year [1] - Earnings per share (EPS) were $48.71, up from $48.11 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $6.22 billion by 0.35%, while the EPS fell short of the consensus estimate of $50.52 by 3.58% [1] Key Metrics - Domestic same-store sales increased by 4.8%, surpassing the six-analyst average estimate of 3.2% [4] - Total same-store sales in constant currency were up 5.1%, compared to the estimated 4.7% by five analysts [4] - The total square footage of stores was 51,818.00 Ksq ft, slightly below the average estimate of 51,899.48 Ksq ft [4] - The number of domestic stores reached 6,627, exceeding the three-analyst average estimate of 6,591 [4] - International same-store sales grew by 2.1%, significantly better than the -0.8% estimated by two analysts [4] Stock Performance - AutoZone shares returned -0.5% over the past month, while the Zacks S&P 500 composite increased by 3.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]
Here's What Key Metrics Tell Us About Victoria's Secret (VSCO) Q2 Earnings
ZACKS· 2025-08-28 14:30
Core Insights - Victoria's Secret reported revenue of $1.46 billion for the quarter ended July 2025, marking a year-over-year increase of 3% and a surprise of +3.78% over the Zacks Consensus Estimate of $1.41 billion [1] - The company's EPS for the same period was $0.33, down from $0.40 a year ago, but exceeded the consensus estimate of $0.13 by +153.85% [1] Financial Performance - Comparable sales for stores and direct channels increased by 4%, significantly outperforming the estimated -0.4% by analysts [4] - The total number of company-operated stores was 787, slightly below the average estimate of 793 from two analysts [4] - The total number of stores in the China joint venture was 63, compared to the estimated 70 by two analysts [4] - Geographic net sales for direct channels were reported at $406.5 million, which is lower than the average estimate of $415.58 million, reflecting a year-over-year decline of -5.5% [4] Stock Performance - Over the past month, shares of Victoria's Secret have returned +16.7%, outperforming the Zacks S&P 500 composite's +1.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
Compared to Estimates, Oneok (OKE) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-09 00:31
Group 1 - Oneok Inc. reported $7.89 billion in revenue for Q2 2025, a year-over-year increase of 61.2%, with EPS of $1.34 compared to $1.33 a year ago [1] - The reported revenue was below the Zacks Consensus Estimate of $8.56 billion, resulting in a surprise of -7.91%, while the EPS met the consensus estimate [1] - Over the past month, Oneok's shares returned -6.7%, contrasting with the Zacks S&P 500 composite's +1.9% change, and the stock holds a Zacks Rank 3 (Hold) [3] Group 2 - Raw feed throughput for Natural Gas Liquids was 1,527.00 MBBL/d, below the average estimate of 1,702.67 MBBL/d [4] - Revenues from Natural Gas Gathering and Processing reached $1.85 billion, significantly exceeding the average estimate of $1.37 billion, representing a year-over-year change of +118.4% [4] - Revenues from Natural Gas Pipelines were $405 million, surpassing the estimated $161.26 million, with a year-over-year increase of +148.5% [4] - Revenues from Refined Products & Crude totaled $2.91 billion, well above the average estimate of $992.77 million [4] - Revenues from Natural Gas Liquids amounted to $3.87 billion, exceeding the average estimate of $3.06 billion, with a year-over-year change of +9.7% [4] - Adjusted EBITDA for Natural Gas Liquids was $673 million, slightly below the estimated $725 million [4] - Adjusted EBITDA for Refined Products & Crude was $557 million, slightly above the average estimate of $549.48 million [4] - Adjusted EBITDA for Natural Gas Pipelines reached $188 million, exceeding the average estimate of $145.59 million [4] - Adjusted EBITDA for Natural Gas Gathering and Processing was $540 million, in line with the average estimate of $538.82 million [4]
ConocoPhillips (COP) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-08-07 14:36
Core Insights - ConocoPhillips reported revenue of $14.74 billion for the quarter ended June 2025, reflecting a 4.3% increase year-over-year, but fell short of the Zacks Consensus Estimate by 1.25% [1] - The company's EPS was $1.42, down from $1.98 in the same quarter last year, but exceeded the consensus estimate of $1.36 by 4.41% [1] Financial Performance - Total production per day was 2,391 million barrels of oil equivalent, surpassing the eight-analyst average estimate of 2,362.71 million barrels [4] - Natural gas production was 4,005 million cubic feet per day, exceeding the seven-analyst average estimate of 3,985.42 million cubic feet [4] - Crude oil production was 1,155 million barrels per day, slightly above the six-analyst average estimate of 1,153.05 million barrels [4] - Sales and other operating revenues were reported at $14 billion, lower than the five-analyst average estimate of $14.68 billion, but showed a year-over-year increase of 2.8% [4] - Equity in earnings of affiliates was $315 million, exceeding the four-analyst average estimate of $259.2 million, but represented a year-over-year decline of 21.8% [4] Market Performance - ConocoPhillips shares returned -1.5% over the past month, while the Zacks S&P 500 composite increased by 1.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]
Here's What Key Metrics Tell Us About Aflac (AFL) Q2 Earnings
ZACKS· 2025-08-05 23:01
Core Insights - Aflac reported revenue of $4.54 billion for the quarter ended June 2025, reflecting an 11.7% decrease year-over-year, but exceeded the Zacks Consensus Estimate by 2.3% [1] - Earnings per share (EPS) for the quarter was $1.78, down from $1.83 in the same quarter last year, surpassing the consensus EPS estimate of $1.71 by 4.09% [1] Financial Performance Metrics - Aflac Japan's Total Benefit/Premium was 66.5%, exceeding the average estimate of 65.3% [4] - Aflac U.S. Total Adjusted Expenses/Total Adjusted Revenue was 36.3%, better than the average estimate of 38.1% [4] - Aflac U.S. Total Adjusted Revenues were reported at $1.73 billion, slightly below the estimated $1.74 billion, but showed a year-over-year increase of 2.6% [4] - Aflac Japan's Total Adjusted Revenues were $2.47 billion, surpassing the estimate of $2.38 billion, with a year-over-year change of 1% [4] - Total net earned premiums for Aflac U.S. were $1.5 billion, compared to the estimate of $1.52 billion, reflecting a 3.4% increase year-over-year [4] - Other income for Aflac Japan was reported at $12 million, significantly higher than the estimated $6.67 million, marking a 71.4% year-over-year increase [4] - Net investment income was $1.08 billion, slightly below the estimate of $907.26 million, showing a 1.3% decrease year-over-year [4] - Total net earned premiums across the company were $3.47 billion, exceeding the estimate of $3.44 billion, with a year-over-year increase of 4.4% [4] - Corporate and other adjusted revenues were $336 million, surpassing the average estimate of $328.5 million, representing a 34.9% year-over-year change [4] Stock Performance - Aflac's shares have returned -4.2% over the past month, contrasting with a +1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings
ZACKS· 2025-08-01 23:01
Core Insights - Moderna reported revenue of $142 million for the quarter ended June 2025, a decrease of 41.1% year-over-year, with an EPS of -$2.13 compared to -$3.33 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $127.17 million by 11.66%, while the EPS also surpassed the consensus estimate of -$2.99 by 28.76% [1] Revenue Breakdown - Product sales in the United States were $88 million, significantly higher than the average estimate of $28.31 million, but represented a year-over-year decline of 45.7% [4] - Product sales in the Rest of the World reached $26 million, below the average estimate of $42.95 million, but showed an 18.2% increase year-over-year [4] - Net product sales totaled $114 million, exceeding the average estimate of $81.42 million, but reflected a 38% decrease compared to the previous year [4] - Other revenue amounted to $28 million, slightly above the average estimate of $25.13 million, but indicated a 50.9% decline year-over-year [4] - Grant revenue was reported at $5 million, compared to the average estimate of $6.16 million [4] - Licensing and royalty revenue was $2 million, significantly lower than the average estimate of $10.65 million [4] - Collaboration revenue reached $4 million, below the average estimate of $7.5 million [4] Stock Performance - Over the past month, Moderna's shares have returned -3.1%, contrasting with the Zacks S&P 500 composite's increase of 2.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]
Here's What Key Metrics Tell Us About ResMed (RMD) Q4 Earnings
ZACKS· 2025-07-31 23:01
ResMed (RMD) reported $1.35 billion in revenue for the quarter ended June 2025, representing a year-over- year increase of 10.2%. EPS of $2.55 for the same period compares to $2.08 a year ago. The reported revenue represents a surprise of +1.87% over the Zacks Consensus Estimate of $1.32 billion. With the consensus EPS estimate being $2.46, the EPS surprise was +3.66%. View all Key Company Metrics for ResMed here>>> Shares of ResMed have returned +8.4% over the past month versus the Zacks S&P 500 composite' ...
Compared to Estimates, Camden (CPT) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-07-31 23:01
Group 1 - Camden reported revenue of $396.51 million for the quarter ended June 2025, reflecting a 2.4% increase year-over-year [1] - The company's EPS for the quarter was $1.70, significantly up from $0.40 in the same quarter last year [1] - Revenue exceeded the Zacks Consensus Estimate of $393.82 million by 0.68%, while EPS also surpassed the consensus estimate of $1.69 by 0.59% [1] Group 2 - Rental revenues were reported at $352.4 million, which was below the estimated $393.98 million by analysts, but still showed a 2.3% increase compared to the previous year [4] - Net Earnings per Share (Diluted) was $0.74, outperforming the average estimate of $0.31 from six analysts [4] - Total non-property income was reported at $11.05 million, significantly higher than the average estimate of $3.43 million from three analysts [4] Group 3 - Camden's stock has returned -1.1% over the past month, contrasting with the Zacks S&P 500 composite's +2.7% change [3] - The company currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
Compared to Estimates, Clorox (CLX) Q4 Earnings: A Look at Key Metrics
ZACKS· 2025-07-31 23:01
Core Insights - Clorox reported revenue of $1.99 billion for the quarter ended June 2025, reflecting a 4.5% increase year-over-year and a surprise of +3.04% over the Zacks Consensus Estimate of $1.93 billion [1] - Earnings per share (EPS) reached $2.87, significantly higher than the $1.82 reported in the same quarter last year, resulting in an EPS surprise of +28.12% compared to the consensus estimate of $2.24 [1] Financial Performance Metrics - Organic Revenue Growth in Health and Wellness was 14%, exceeding the average estimate of 6.3% from four analysts [4] - Organic Revenue Growth in International markets was 1%, slightly below the average estimate of 2.4% [4] - Organic Revenue Growth in Lifestyle was 3%, compared to the average estimate of 6.3% [4] - Organic Revenue Growth in Household products was 7%, surpassing the average estimate of 4.6% [4] - Overall Organic Sales Growth was 8%, above the average estimate of 5.4% [4] Revenue Breakdown - Net Revenue for Health and Wellness was $741 million, exceeding the average estimate of $692.86 million, representing a year-over-year increase of +13.7% [4] - Net Revenue for International markets was $269 million, slightly below the average estimate of $249.98 million, with a year-over-year change of -0.7% [4] - Net Revenue for Lifestyle products was $339 million, compared to the average estimate of $349.59 million, reflecting a +3.4% year-over-year change [4] - Net Revenue for Household products was $639 million, above the average estimate of $626.55 million, indicating a +7% year-over-year increase [4] Income Before Taxes - Income before income taxes for Health and Wellness was $243 million, surpassing the average estimate of $219.1 million [4] - Income before income taxes for Corporate and Other segments was -$56 million, worse than the average estimate of -$26.67 million [4] - Income before income taxes for International markets was $23 million, slightly above the average estimate of $21.21 million [4]